The most interesting compound, named VP18/58 (molecular structure reported in Figure 1) [44], was able to reduce HO-1 enzymatic activity and the cell invasion rate by interfering with the angiogenesis in GBM cells. This evidence concerns the gene HMOX1 and glioblastoma.